HomeOcrelizumabOcrelizumab + Corticosteroids

Does Ocrelizumab Interact with Corticosteroids?

Ocrelizumab and Corticosteroids have a moderate drug interaction according to U.S. FDA drug labeling data. Immunosuppressant doses of corticosteroids used concomitantly with OCREVUS are expected to increase the risk of immunosuppression. The mechanism involves additive immunosuppressive effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ocrelizumab Class
CD20-directed Cytolytic Antibody
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ocrelizumab and Corticosteroids occurs because additive immunosuppressive effects. Clinically, this means immunosuppressant doses of corticosteroids used concomitantly with ocrevus are expected to increase the risk of immunosuppression. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Ocrelizumab and your doctor is considering prescribing Corticosteroids (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ocrelizumab(Ocrevus)+💊 Corticosteroids

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
CD20-directed Cytolytic Antibody
Drug B class
Source
NLP:ocrelizumab

What this means in plain English

Immunosuppressant doses of corticosteroids used concomitantly with OCREVUS are expected to increase the risk of immunosuppression.

What the FDA label says

"additive immunosuppressive effects"

📖 Source: NLP:ocrelizumab

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Ocrelizumab and Corticosteroids against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.